Parametric estimation procedures for screening programmes: Stable and nonstable disease models for multimodality case finding

Biometrika

Volumn 86, Issue 3, 1999, Pages 503-515

  Shen, Y U ^a   Zelen, Marvin ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

; stable disease model; Conditional likelihood; Multiple screening examination; Nonstable disease model; Sensitivity; Sojourn time

Indexed keywords

EID: 0000097757     PISSN: 00063444     EISSN: None     Source Type: Journal    
DOI: 10.1093/biomet/86.3.503     Document Type: Article

References (26)

1. BAKER, S. G. & CHU, K. C. (1990). Evaluating screening for the early detection and treatment of cancer without using a randomized control group. J. Am. Statist. Assoc. 85, 321-7.
2. BASU, D. (1977). On the elimination of nuisance parameters. J. Am. Statist. Assoc. 72, 355-66.
3. BROOKMEYER, R. & DAY, N. E. (1987). Two-stage models for the analysis of cancer screening data. Biometrics 43, 657-69.
4. Cox, D. R. (1975). Partial likelihood. Biometrika 62, 269-76.
5. Cox, D. R. (1988). Some aspects of conditional and asymptotic inference: A review. Sankhyâ 50 A, 314-37.
6. Cox, D. R. & REID, N. (1987). Parameter orthogonality and approximate conditional inference (with Discussion). J. R. Statist. Soc. B 49, 1-39.
7. DAY, N. E. & WALTER, S. D. (1984). Simplified models of screening for chronic disease: Estimation procedures from mass screening programmes. Biometrics 40, 1-13.
8. ETZIONI, R. & SHEN, Y. (1997). Estimating asymptotic duration in cancer: The AIDS connection. Statist. Med. 16, 627-44.
9. GAY, D. M. (1983). A trust-region approach to linearly constrained optimization. In Lecture Notes in Mathematics: Numerical Analysis, Ed. A. Dold and B. Eckmann, pp. 72-105. Berlin: Springer.
10. Hu, P. & ZELEN, M. (1997). Planning clinical trials to evaluate early detection programmes. Biometrika 84, 817-30.
11. HUTCHINSON, G. B. & SHAPIRO, S. (1968). Lead time gained by diagnostic screening for breast cancer. J. Nat. Cancer Inst. 41, 665-81.
12. LEE, S. & ZELEN, M. (1998). Scheduling periodic examinations for the early detection of disease: Applications to breast cancer. J. Am. Statist. Assoc. 93, 1271-81.
13. Louis, T. A., ALBERT, A. & HEGHINIAN, S. (1978). Screening for the early detection of cancer -III. Estimation of disease natural history. Math. Biosci. 40, 111-44.
14. MILLER, A. B., BAINES, C. J., To, T. & WALL, C. (1992a). Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can. Med. Assoc. J. 147,1459-76.
15. MILLER, A. B., BAINES, C. J., To, T. & WALL, C. (1992b). Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. Can. Med. Assoc. J. 147,1477-88.
16. PARMIGIANI, G. (1993). On optimal screening ages. J. Am. Statist. Assoc. 88, 622-8.
17. PARMIGIANI, G. (1997). Timing medical examinations via intensity functions. Biometrika 84, 803-16.
18. PEREIRA, C. A. & LINDLEY, D. V. (1987). Examples questioning the use of partial likelihood. Statistician 36, 15-20.
19. PROROK, P. C. (1976a). The theory of periodic screening. I: Lead time and proportion detected. Adv. Appl. Prob. 8, 127-43.
20. PROROK, P. C. (1976b). The theory of periodic screening. II: Doubly bounded recurrence times and mean lead time and detection probability estimation. Adv. Appl. Prob. 8, 460-76.
21. SHAPIRO, S. (1977). Evidence of screening for breast cancer from a randomised trial. Cancer 39, 2772-82.
22. SHAPIRO, S., VENET, W., STRAX, P. & VENET, L. (1988). Periodic Screening for Breast Cancer. The Health Insurance Plan Project and its Sequelae, 1963-1986. Baltimore, MD: Johns Hopkins University Press.
23. STRAATMAN, H., PEER, P. G. M. & VERBEEK, A. L. M. (1997). Estimating lead time and sensitivity in a screening program without estimating the incidence in the screened group. Biometrics 53, 217-29.
24. WALTER, S. D. & DAY, N. E. (1983). Estimation of the duration of a pre-clinical disease state using screening data. Am. J. Epidem. 118, 856-86.
25. ZELEN, M. (1993). Optimal scheduling of examination for the early detection of disease. Biometrika 80, 279-93.
26. ZELEN, M. & FEINLEIB, M. (1969). On the theory of screening for chronic diseases. Biometrika 56, 601-14.